SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Coaxia Inc. Announces First Patient Enrolled In Pivotal Trial Evaluating NeuroFlo(TM) Cerebral Perfusion Augmentation For Ischemic Stroke